Talem Therapeutics (Talem) is a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) and is focused on the discovery and development of next-generation, fully human, monoclonal, therapeutic antibodies to target multiple disease indications.
Using the proprietary antibody discovery platforms and innovative technologies housed at ImmunoPrecise Antibodies, Talem aims to accelerate novel, high-value, therapeutic antibody tre...
Talem Therapeutics (Talem) is a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) and is focused on the discovery and development of next-generation, fully human, monoclonal, therapeutic antibodies to target multiple disease indications.
Using the proprietary antibody discovery platforms and innovative technologies housed at ImmunoPrecise Antibodies, Talem aims to accelerate novel, high-value, therapeutic antibody treatments to the clinic.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.